Fig. 1From: Research based on existing clinical data and biospecimens: a systematic study of patients’ opinionsThe respondents’ opinions on secondary research in their health information, their biospecimen and the genetic data derived from it (presented as percent). We asked if secondary research in health information, biospecimen and genetic data was okay (1) with active consent ("opt-in"), (2) with passive consent ("opt-out"), (3) without information or (4) not okayBack to article page